Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Sarah K. Brode"'
Autor:
Jonathon R. Campbell, Placide Nsengiyumva, Leslie Y. Chiang, Frances Jamieson, Hadeel Khadawardi, Henry K.-H. Mah, Olivia Oxlade, Hayden Rasberry, Elizabeth Rea, Kamila Romanowski, Natasha F. Sabur, Beate Sander, Aashna Uppal, James C. Johnston, Kevin Schwartzman, Sarah K. Brode
Publikováno v:
Emerging Infectious Diseases, Vol 28, Iss 9, Pp 1814-1823 (2022)
We estimated costs of managing different forms of tuberculosis (TB) across Canada by conducting a retrospective chart review and cost assessment of patients treated for TB infection, drug-susceptible TB (DS TB), isoniazid-resistant TB, or multidrug-r
Externí odkaz:
https://doaj.org/article/25e05c9e3aec44e785c4dd1e75d316db
Publikováno v:
Emerging Infectious Diseases, Vol 28, Iss 8, Pp 1589-1596 (2022)
In mid-2014, Public Health Ontario Laboratories identified coincident increasing Mycobacterium avium isolation and falling M. xenopi isolation in the Toronto, Ontario, Canada, area. We performed a retrospective cohort of all patients in a Toronto cli
Externí odkaz:
https://doaj.org/article/cb7e56ae67004fbcbdbb6ce3703f0722
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background The World Health Organization recommends intravenous amikacin for the treatment of MDR-TB at a dose of 15 mg/kg. However, higher doses are associated with significant toxicity. Methods Patients with MDR-TB treated at our instituti
Externí odkaz:
https://doaj.org/article/b41433924bb7405f847e2a94f4c08dc5
Autor:
Lauren C. Ramsay, Emily Shing, John Wang, Theodore K. Marras, Jeffrey C. Kwong, Sarah K. Brode, Frances B. Jamieson, Beate Sander
Publikováno v:
Emerging Infectious Diseases, Vol 26, Iss 9, Pp 2097-2107 (2020)
To determine incidence-based healthcare costs attributable to nontuberculous mycobacterial (NTM) pulmonary disease (PD) and NTM pulmonary isolation (PI), from the healthcare payer perspective, we conducted a population-based matched cohort study in O
Externí odkaz:
https://doaj.org/article/fd3d774d807a45b68cc53f40ce1568fa
Autor:
Sarah K. Brode, Hannah Chung, Michael A. Campitelli, Jeffrey C. Kwong, Alex Marchand-Austin, Kevin L. Winthrop, Frances B. Jamieson, Theodore K. Marras
Publikováno v:
Emerging Infectious Diseases, Vol 25, Iss 7, Pp 1271-1280 (2019)
Surveys suggest that clinicians diverge from guidelines when treating Mycobacterium avium complex (MAC) pulmonary disease (PD). To determine prescribing patterns, we conducted a cohort study of adults >66 years of age in Ontario, Canada, with MAC or
Externí odkaz:
https://doaj.org/article/41e01e6e15ab4c548719949d32aca233
Publikováno v:
BMC Pharmacology and Toxicology, Vol 20, Iss 1, Pp 1-9 (2019)
Abstract Background Treatment guidelines suggest either a low-dose or high-dose approach when prescribing amikacin for nontuberculous mycobacterial pulmonary disease (NTM PD), but data supporting the low-dose approach are limited. The purpose of this
Externí odkaz:
https://doaj.org/article/a4e45201c8134e809fc4ddd9332bdcf7
Publikováno v:
Emerging Infectious Diseases, Vol 23, Iss 11, Pp 1898-1901 (2017)
In Ontario, Canada, during 1998–2010, nontuberculous mycobacteria (NTM) from pulmonary sites comprised 96% of species/patient combinations isolated; annual rates of isolation and cases increased steadily. NTM isolates from nonpulmonary sites compri
Externí odkaz:
https://doaj.org/article/88c7f07d5ae24ad1bb843e590edc44fb
Autor:
Theodore K. Marras, Michael A. Campitelli, Hong Lu, Hannah Chung, Sarah K. Brode, Alex Marchand-Austin, Kevin L. Winthrop, Andrea S. Gershon, Jeffrey C. Kwong, Frances B. Jamieson
Publikováno v:
Emerging Infectious Diseases, Vol 23, Iss 3, Pp 468-476 (2017)
Survival implications of nontuberculous mycobacterial pulmonary disease (NTM-PD) and NTM pulmonary isolation without disease (NTM-PI) are unclear. To study deaths associated with NTM-PD and NTM-PI and differences in survival between them, we conducte
Externí odkaz:
https://doaj.org/article/11560960fc514f5289bdcbd5017a0b71
Publikováno v:
Chest. 163:281-291
Publikováno v:
Annals of the American Thoracic Society. 19:925-932
RATIONALE Additional biomarkers are needed to guide initiation of treatment for Mycobacterium avium pulmonary disease (Mav-PD). Time to positive sputum culture detection (TTP) may offer potential prognostic and monitoring value. OBJECTIVE To determin